{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:19:35Z","timestamp":1788297575508,"version":"build-2803163510"},"reference-count":182,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["WK9100000001"],"award-info":[{"award-number":["WK9100000001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["82402072"],"award-info":[{"award-number":["82402072"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100745"],"award-info":[{"award-number":["32100745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272301"],"award-info":[{"award-number":["82272301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["2022i01020025"],"award-info":[{"award-number":["2022i01020025"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012402","name":"CAS Key Laboratory of Receptor Research","doi-asserted-by":"publisher","award":["XDB0490000"],"award-info":[{"award-number":["XDB0490000"]}],"id":[{"id":"10.13039\/501100012402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2304102"],"award-info":[{"award-number":["2022YFC2304102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303300"],"award-info":[{"award-number":["2022YFC2303300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.drudis.2025.104375","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:24:39Z","timestamp":1746725079000},"page":"104375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["NLRP3 inflammasome: From drug target to drug discovery"],"prefix":"10.1016","volume":"30","author":[{"given":"Ling","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songquan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengchuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104375_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1206720","article-title":"Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity","volume":"13","author":"Zheng","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2025.104375_b0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.iac.2021.07.003","article-title":"Innate immunity","volume":"41","author":"Kaur","year":"2021","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.drudis.2025.104375_b0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-animal-022513-114201","article-title":"Origin and evolution of adaptive immunity","volume":"2","author":"Boehm","year":"2014","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.drudis.2025.104375_b0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.drudis.2025.104375_b0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0030","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1084\/jem.20161955","article-title":"Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells","volume":"214","author":"Watanabe","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104375_b0035","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","article-title":"B cells and humoral immunity in atherosclerosis","volume":"114","author":"Tsiantoulas","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2025.104375_b0040","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107411","article-title":"Nod-like receptors: the relevant elements of glioblastoma\u2019s prognostic puzzle","volume":"208","author":"Grabiec","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104375_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","article-title":"NLRP inflammasomes in health and disease","volume":"5","author":"Xu","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.drudis.2025.104375_b0060","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.248344","article-title":"Recent insights into the regulatory networks of NLRP3 inflammasome activation","volume":"133","author":"Weber","year":"2020","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0065","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202637","article-title":"ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activation","volume":"218","author":"Li","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104375_b0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","article-title":"NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma","volume":"108","author":"McKee","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1042\/EBC20220067","article-title":"Concerted actions of PRR- and NLR-mediated immunity","volume":"66","author":"Rhodes","year":"2022","journal-title":"Essays Biochem"},{"key":"10.1016\/j.drudis.2025.104375_b0085","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0090","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41401-021-00693-6","article-title":"Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages","volume":"43","author":"Song","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.drudis.2025.104375_b0095","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/eji.201545958","article-title":"Potassium efflux fires the canon: potassium efflux as a common trigger for canonical and noncanonical NLRP3 pathways","volume":"45","author":"Rivers-Auty","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12035-022-03098-6","article-title":"Acrylamide induces neurotoxicity in SH-SY5Y cells via NLRP3-mediated pyroptosis","volume":"60","author":"Zhao","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.drudis.2025.104375_b0105","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s42003-024-07204-3","article-title":"Interferon signalling and non-canonical inflammasome activation promote host protection against multidrug-resistant Acinetobacter baumannii","volume":"7","author":"Li","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101844","article-title":"The noncanonical inflammasome-induced pyroptosis and septic shock","volume":"70","author":"Wu","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0115","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3390\/cells12222597","article-title":"Non-canonical inflammasome pathway: The role of cell death and inflammation in ehrlichiosis","volume":"12","author":"Sharma","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104375_b0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12974-023-02709-w","article-title":"ASC specks exacerbate \u03b1\u2011synuclein pathology via amplifying NLRP3 inflammasome activities","volume":"20","author":"Zheng","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.drudis.2025.104375_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188864","article-title":"What are NLRP3-ASC specks? An experimental progress of 22 years of inflammasome research","volume":"14","author":"Nagar","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0130","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, pyroptosis, and necroptosis\u2014Oh my! The many ways a cell can die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J Mol Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9579868","article-title":"The Janus-faced role of antioxidants in cancer cachexia: new insights on the established concepts","volume":"2016","author":"Assi","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.drudis.2025.104375_b0145","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/ITT.S495564","article-title":"NLRP3 inflammasome upregulates PD-L1 in ovarian cancer and contributes to an immunosuppressive microenvironment","volume":"13","author":"Pan","year":"2024","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41435-024-00309-z","article-title":"The role of NLRP3 and NLRP12 inflammasomes in glioblastoma","volume":"25","author":"Rajkhowa","year":"2024","journal-title":"Genes Immun"},{"key":"10.1016\/j.drudis.2025.104375_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116360","article-title":"Chloranthalactone B covalently binds to the NACHT domain of NLRP3 to attenuate NLRP3-driven inflammation","volume":"226","author":"Tang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2025.104375_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117861","article-title":"MCC950 mitigates SIRT3-NLRP3-driven inflammation and rescues post-stroke neurogenesis","volume":"183","author":"Prakash","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2025.104375_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122533","article-title":"MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes","volume":"307","author":"Zhu","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2025.104375_b0170","doi-asserted-by":"crossref","first-page":"12225","DOI":"10.18632\/aging.206057","article-title":"Melatonin downregulates angiogenesis and lymphangiogenesis by regulating tumor-associated macrophages via NLRP3 inflammasomes in lung adenocarcinoma","volume":"16","author":"Zhao","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.drudis.2025.104375_b0175","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/ijms21103422","article-title":"Molecular mechanisms of premature aging in hemodialysis: The complex interplay between innate and adaptive immune dysfunction","volume":"21","author":"Losappio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0180","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.3390\/ijms22126350","article-title":"Targeting glycolysis in macrophages confers protection against pancreatic ductal adenocarcinoma","volume":"22","author":"Penny","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0185","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70061","article-title":"Microglial priming by IFN-\u03b3 involves STAT1-mediated activation of the NLRP3 inflammasome","volume":"30","author":"He","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2021.04.122","article-title":"NLRP3 induces the autocrine secretion of IL-1\u03b2 to promote epithelial-mesenchymal transition and metastasis in breast cancer","volume":"560","author":"Wang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2025.104375_b0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1158\/2326-6066.CIR-22-0398","article-title":"IL18 receptor signaling regulates tumor-reactive CD8+ T-cell exhaustion via activation of the IL2\/STAT5\/mTOR pathway in a pancreatic cancer model","volume":"11","author":"Lutz","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.drudis.2025.104375_b0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2021.06.014","article-title":"NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1\u03b2\/Th1\/IFN-\u03b3 in acute myeloid leukemia","volume":"520","author":"Liu","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2025.104375_b0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/cancers12010193","article-title":"Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS\/NF-\u03baB\/NLRP3\/GSDMD signal axis in non-small cell lung cancer","volume":"12","author":"Teng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2025.104375_b0210","doi-asserted-by":"crossref","first-page":"934","DOI":"10.62347\/MKAN3550","article-title":"Quercetin-induced pyroptosis in colon cancer through NEK7-mediated NLRP3 inflammasome-GSDMD signaling pathway activation","volume":"14","author":"Feng","year":"2024","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.drudis.2025.104375_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1002269","article-title":"Huoxiang Zhengqi alleviates azoxymethane\/dextran sulfate sodium-induced colitis-associated cancer by regulating Nrf2\/NF-\u03baB\/NLRP3 signaling","volume":"13","author":"Dong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104375_b0220","doi-asserted-by":"crossref","first-page":"14013","DOI":"10.3390\/ijms241814013","volume":"24","author":"Nagoor Meeran","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0225","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6666499","article-title":"Hedyotis diffusa plus Scutellaria barbata suppress the growth of non-small-cell lung cancer via NLRP3\/NF-\u03baB\/MAPK signaling pathways","volume":"2021","author":"Lv","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.drudis.2025.104375_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110979","article-title":"ZNF70 regulates IL-1\u03b2 secretion of macrophages to promote the proliferation of HCT116 cells via activation of NLRP3 inflammasome and STAT3 pathway in colitis-associated colorectal cancer","volume":"114","author":"Zhang","year":"2024","journal-title":"Cell Signal"},{"key":"10.1016\/j.drudis.2025.104375_b0235","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/s41467-019-12370-8","article-title":"NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis","volume":"10","author":"Ershaid","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104375_b0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexcr.2016.03.009","article-title":"Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells","volume":"342","author":"Wang","year":"2016","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.drudis.2025.104375_b0245","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/carcin\/bgs256","article-title":"Genetic variation and alterations of genes involved in NF\u03baB\/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer","volume":"33","author":"Ungerb\u00e4ck","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.drudis.2025.104375_b0250","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.1073\/pnas.1209171109","article-title":"Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis","volume":"109","author":"Drexler","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104375_b0255","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1158\/0008-5472.CAN-12-0509","article-title":"NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases","volume":"72","author":"Chow","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2025.104375_b0260","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/onc.2017.381","article-title":"MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2025.104375_b0265","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","article-title":"Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma","volume":"75","author":"Chen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0270","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104375_b0275","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fonc.2019.00588","article-title":"Correlation between the NLRP3 inflammasome and the prognosis of patients with LSCC","volume":"9","author":"Xue","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2025.104375_b0280","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3892\/or.2016.4569","article-title":"Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells","volume":"35","author":"Wang","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.drudis.2025.104375_b0285","doi-asserted-by":"crossref","first-page":"108571","DOI":"10.18632\/oncotarget.21010","article-title":"NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2025.104375_b0290","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.taap.2013.03.027","article-title":"Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome","volume":"270","author":"Ahmad","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.drudis.2025.104375_b0295","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2025.104375_b0300","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1084\/jem.20161707","article-title":"NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma","volume":"214","author":"Daley","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104375_b0305","doi-asserted-by":"crossref","first-page":"28183","DOI":"10.18632\/oncotarget.8594","article-title":"Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation","volume":"7","author":"Panchanathan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2025.104375_b0310","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20100050","article-title":"The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"Allen","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104375_b0315","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2015.08.013","article-title":"The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity","volume":"43","author":"Dupaul-Chicoine","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2025.104375_b0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/labinvest.2013.126","article-title":"Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression","volume":"94","author":"Wei","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.drudis.2025.104375_b0325","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 inflammasome activation in cancer: A double-edged sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23444","article-title":"Saikosaponin-D induces the pyroptosis of lung cancer by increasing ROS and activating the NF-\u03baB\/NLRP3\/caspase-1\/GSDMD pathway","volume":"37","author":"Chen","year":"2023","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.drudis.2025.104375_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154909","article-title":"Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy","volume":"116","author":"Luo","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2025.104375_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.930797","article-title":"Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100\/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways","volume":"9","author":"Quagliariello","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.drudis.2025.104375_b0345","doi-asserted-by":"crossref","first-page":"24271","DOI":"10.18632\/aging.203678","article-title":"Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany, NY)"},{"key":"10.1016\/j.drudis.2025.104375_b0350","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2217\/fon-2019-0317","article-title":"REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer","volume":"15","author":"Oronsky","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.drudis.2025.104375_b0355","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/ph15070798","article-title":"Inhibition of NLRP3 by fermented quercetin decreases resistin-induced chemoresistance to 5-fluorouracil in human colorectal cancer cells","volume":"15","author":"Lee","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2025.104375_b0360","doi-asserted-by":"crossref","first-page":"11108","DOI":"10.3390\/ijms222011108","article-title":"NLRP3 inflammasome inhibitor BAY-117082 reduces oral squamous cell carcinoma progression","volume":"22","author":"Scuderi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105748","article-title":"Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis","volume":"170","author":"Yuan","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104375_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112068","article-title":"Reniformin A suppresses non-small cell lung cancer progression by inducing TLR4\/NLRP3\/caspase-1\/GSDMD-dependent pyroptosis","volume":"133","author":"Zhu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.drudis.2025.104375_b0375","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13148-017-0312-z","article-title":"The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry","volume":"9","author":"Zhao","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.drudis.2025.104375_b0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/vaccines9020138","article-title":"Targeting innate immunity in cancer therapy","volume":"9","author":"Rameshbabu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.drudis.2025.104375_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106033","article-title":"Pathway network of pyroptosis and its potential inhibitors in acute kidney injury","volume":"175","author":"Li","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104375_b0390","article-title":"Interleukin-18 and IL-18BP in inflammatory dermatological diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0395","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China Lancet"},{"key":"10.1016\/j.drudis.2025.104375_b0400","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104375_b0405","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s11010-023-04848-3","article-title":"A brief overview of SARS-CoV-2 infection and its management strategies: a recent update","volume":"479","author":"Das","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.drudis.2025.104375_b0410","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027400","article-title":"The clinical characters and prognosis of COVID-19 patients with multiple organ dysfunction","volume":"100","author":"Cui","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drudis.2025.104375_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2020.08.011","article-title":"The novel coronavirus disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies","volume":"551","author":"Seyed Hosseini","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2025.104375_b0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.drudis.2025.104375_b0425","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: Immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.drudis.2025.104375_b0430","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.drudis.2025.104375_b0435","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7150\/ijbs.59272","article-title":"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy","volume":"18","author":"Jiang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0440","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2025.104375_b0445","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cytogfr.2021.06.002","article-title":"The NLRP3 inflammasome and COVID-19: activation, pathogenesis and therapeutic strategies","volume":"61","author":"Zhao","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.drudis.2025.104375_b0450","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104375_b0455","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104375_b0460","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12035-021-02593-6","article-title":"SARS-CoV-2 spike glycoprotein S1 induces neuroinflammation in BV-2 microglia","volume":"59","author":"Olajide","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.drudis.2025.104375_b0465","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","article-title":"Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone","volume":"44","author":"Olajide","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.drudis.2025.104375_b0470","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400459","article-title":"MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions","volume":"357","author":"Zheng","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.drudis.2025.104375_b0475","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2025.104375_b0480","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/cpt.2544","article-title":"Neurodegenerative diseases: the value of early predictive end points","volume":"111","author":"Janicki Hsieh","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0485","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2174\/1566524023666230907093451","article-title":"Neurodegenerative diseases: new hopes and perspectives","volume":"24","author":"Bhat","year":"2024","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.drudis.2025.104375_b0490","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9999146","article-title":"Neuroinflammation: An integrating overview of reactive-neuroimmune cell interactions in health and disease","volume":"2021","author":"K\u00f6lliker-Frers","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.drudis.2025.104375_b0495","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/biom13111568","article-title":"Neuroinflammation in Alzheimer\u2019s disease: a potential role of nose-picking in pathogen entry via the olfactory system?","volume":"13","author":"Zhou","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2025.104375_b0500","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11910-023-01282-2","article-title":"Neuroinflammation in acute ischemic and hemorrhagic stroke","volume":"23","author":"Alsbrook","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.drudis.2025.104375_b0505","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.WNL.0000123249.58898.E0","article-title":"Amyloid \u03b2(1\u201342) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease","volume":"62","author":"Schoonenboom","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2025.104375_b0510","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/ejn.15599","article-title":"A closer look at the mycobiome in Alzheimer\u2019s disease: fungal species, pathogenesis and transmission","volume":"55","author":"Phuna","year":"2022","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.drudis.2025.104375_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.drudis.2025.104375_b0520","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson\u2019s disease\u2014from neurodegeneration to therapeutic opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104375_b0525","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","article-title":"Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies","volume":"48","author":"Moradi Vastegani","year":"2023","journal-title":"Neurochem Res"},{"key":"10.1016\/j.drudis.2025.104375_b0530","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-023-00600-z","article-title":"Translational molecular imaging and drug development in Parkinson\u2019s disease","volume":"18","author":"Haider","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.drudis.2025.104375_b0535","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0540","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson\u2019s disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.drudis.2025.104375_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111532","article-title":"Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice","volume":"41","author":"Li","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2025.104375_b0550","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40478-019-0725-3","article-title":"Cerebrospinal fluid from Alzheimer\u2019s disease patients promotes tau aggregation in transgenic mice","volume":"7","author":"Skachokova","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.drudis.2025.104375_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149129","article-title":"A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson\u2019s disease","volume":"1842","author":"Chatterjee","year":"2024","journal-title":"Brain Res"},{"key":"10.1016\/j.drudis.2025.104375_b0560","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-023-02912-9","article-title":"Proteomic profiling identifies novel inflammation-related plasma proteins associated with ischemic stroke outcome","volume":"20","author":"Angerfors","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.drudis.2025.104375_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1388654","article-title":"Correlation of brain tissue volume loss with inflammatory biomarkers IL1\u03b2, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population","volume":"16","author":"Lee","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2025.104375_b0570","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.3390\/ijms23168979","article-title":"Targeting NLRP3-mediated neuroinflammation in Alzheimer\u2019s disease treatment","volume":"23","author":"Barczuk","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0575","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0580","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.drudis.2025.104375_b0585","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.805169","article-title":"Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"15","author":"Hulse","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.drudis.2025.104375_b0590","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104375_b0595","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3233\/JAD-240012","article-title":"TLR4\/Rac1\/NLRP3 pathway mediates amyloid-\u03b2-induced neuroinflammation in Alzheimer\u2019s disease","volume":"99","author":"Zhu","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.drudis.2025.104375_b0600","article-title":"Mechanism of inhibition of TLR4\/NF\u03baB\/NLRP3 inflammatory pathway against AD based on the network pharmacology of Erjing Pills","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drudis.2025.104375_b0605","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104375_b0610","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104375_b0615","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3233\/JAD-210400","article-title":"A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in Alzheimer\u2019s disease transgenic mice","volume":"82","author":"Kuwar","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.drudis.2025.104375_b0620","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0625","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","article-title":"MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer\u2019s disease","volume":"116","author":"Naeem","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.drudis.2025.104375_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577543","article-title":"A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease","volume":"354","author":"Huang","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.drudis.2025.104375_b0635","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","article-title":"Inflammasome inhibition protects dopaminergic neurons from \u03b1-synuclein pathology in a model of progressive Parkinson\u2019s disease","volume":"20","author":"Grotemeyer","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.drudis.2025.104375_b0640","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human Phase 1 studies (single ascending dose and multiple ascending dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.drudis.2025.104375_b0645","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/ijms22031062","article-title":"Pathomechanism characterization and potential therapeutics identification for Parkinson\u2019s disease targeting neuroinflammation","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0650","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acsmedchemlett.4c00056","article-title":"Advancements in predictive medicine: NLRP3 inflammasome inhibitors and AI-driven predictive health analytics","volume":"15","author":"Kargbo","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104375_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117874","article-title":"Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors","volume":"112","author":"Tian","year":"2024","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2025.104375_b0660","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.jmedchem.3c02098","article-title":"Discovery of potent, orally bioavailable, tricyclic NLRP3 inhibitors","volume":"67","author":"Velcicky","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104375_b0665","doi-asserted-by":"crossref","first-page":"20780","DOI":"10.1021\/acs.jmedchem.4c02350","article-title":"Discovery of NP3-253, a potent brain penetrant inhibitor of the NLRP3 inflammasome","volume":"67","author":"Mackay","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104375_b0670","doi-asserted-by":"crossref","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","article-title":"Discovery of clinical candidate NT-0796, a brain-penetrant and highly potent NLRP3 inflammasome inhibitor for neuroinflammatory disorders","volume":"66","author":"Harrison","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104375_b0675","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/jpet.123.002013","article-title":"Reversal of high fat diet-induced obesity, systemic inflammation, and astrogliosis by the NLRP3 inflammasome inhibitors NT-0249 and NT-0796","volume":"388","author":"Thornton","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129987","article-title":"Design, synthesis and biological evaluation of sulfonylurea derivatives as NLRP3 inflammasome inhibitors","volume":"114","author":"Feng","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104375_b0685","article-title":"Assessment of spatial transcriptomics for oncology discovery","volume":"2","author":"Lyubetskaya","year":"2022","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.drudis.2025.104375_b0690","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/HEP.0000000000000601","article-title":"Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response","volume":"80","author":"Failli","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2025.104375_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107208","article-title":"Time-dependent proteomics and drug response in expanding cancer cells","volume":"204","author":"Pan","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104375_b0700","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/2159-8290.CD-21-0576","article-title":"Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer toward androgen independence","volume":"12","author":"Linder","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2025.104375_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102362","article-title":"Spatial metabolomics principles and application to cancer research","volume":"76","author":"Planque","year":"2023","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0710","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0715","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/EBC20210020","article-title":"Nuclear receptors: from molecular mechanisms to therapeutics","volume":"65","author":"Frigo","year":"2021","journal-title":"Essays Biochem"},{"key":"10.1016\/j.drudis.2025.104375_b0720","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/1940-6207.CAPR-09-0085","article-title":"Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice","volume":"2","author":"Liby","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.drudis.2025.104375_b0725","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40487-017-0046-2","article-title":"A review of fulvestrant in breast cancer","volume":"5","author":"Nathan","year":"2017","journal-title":"Oncol Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0730","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/0008-5472.CAN-13-1836","article-title":"Small molecule agonists of PPAR-\u03b3 exert therapeutic effects in esophageal cancer","volume":"74","author":"Sawayama","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2025.104375_b0735","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104375_b0740","first-page":"1207","article-title":"Nuclear receptors: recent drug discovery for cancer therapies","volume":"40","author":"Zhao","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.drudis.2025.104375_b0745","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure","volume":"32","author":"de Th\u00e9","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2025.104375_b0750","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/2159-8290.CD-17-0399","article-title":"Superenhancer analysis defines novel epigenomic subtypes of non-APL AML, including an RAR\u03b1 dependency targetable by SY-1425, a potent and selective RAR\u03b1 agonist","volume":"7","author":"McKeown","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2025.104375_b0755","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.10.007","article-title":"Cutaneous T-cell lymphomas: focusing on novel agents in relapsed and refractory disease","volume":"61","author":"Argnani","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.drudis.2025.104375_b0760","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-023-02834-7","article-title":"ERR\u03b1 promotes glycolytic metabolism and targets the NLRP3\/caspase-1\/GSDMD pathway to regulate pyroptosis in endometrial cancer","volume":"42","author":"Su","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2025.104375_b0765","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.2147\/OTT.S218240","article-title":"NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0770","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/cdd.2014.117","article-title":"Liver X receptor \u03b2 activation induces pyroptosis of human and murine colon cancer cells","volume":"21","author":"Derang\u00e8re","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.drudis.2025.104375_b0775","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-associated defective virus particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104375_b0780","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1073\/pnas.1001673107","article-title":"A viral assembly factor promotes AAV2 capsid formation in the nucleolus","volume":"107","author":"Sonntag","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104375_b0785","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/v16030442","article-title":"Natural adeno-associated virus serotypes and engineered adeno-associated virus capsid variants: tropism differences and mechanistic insights","volume":"16","author":"Lopez-Gordo","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104375_b0790","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41434-020-0140-1","article-title":"AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo","volume":"28","author":"Yin","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.drudis.2025.104375_b0795","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101066R","article-title":"Disease mechanisms of X-linked cone dystrophy caused by missense mutations in the red and green cone opsins","volume":"35","author":"Zhu","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2025.104375_b0800","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.omtn.2020.03.009","article-title":"Enhanced transduction of human hematopoietic stem cells by AAV6 vectors: implications in gene therapy and genome editing","volume":"20","author":"Yang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.drudis.2025.104375_b0805","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.7150\/thno.62376","article-title":"TNF-\u03b1-dependent neuronal necroptosis regulated in Alzheimer\u2019s disease by coordination of RIPK1-p62 complex with autophagic UVRAG","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2025.104375_b0810","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01330-23","article-title":"Identification of host essential factors for recombinant AAV transduction of the polarized human airway epithelium","volume":"97","author":"Hao","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104375_b0815","article-title":"Miltefosine as a PPM1A activator improves AD-like pathology in mice by alleviating tauopathy via microglia\/neurons crosstalk","volume":"26","author":"Lv","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.drudis.2025.104375_b0820","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12974-024-03066-y","article-title":"Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer\u2019s disease","volume":"21","author":"Ng","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.drudis.2025.104375_b0825","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","article-title":"TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson\u2019s disease mice and LPS-induced BV2 Cells","volume":"61","author":"Huang","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.drudis.2025.104375_b0830","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.21037\/atm-22-5159","article-title":"BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson\u2019s disease","volume":"10","author":"Ying","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.drudis.2025.104375_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155227","article-title":"Cancer stem cells: the important role of CD markers, signaling pathways, and microRNAs","volume":"256","author":"Gholamzad","year":"2024","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.drudis.2025.104375_b0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102502","article-title":"MicroRNA:Siglec crosstalk in cancer progression","volume":"81","author":"Mustafov","year":"2024","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0845","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pbiomolbio.2019.05.004","article-title":"MicroRNAs as important regulators of the NLRP3 inflammasome","volume":"150","author":"Zamani","year":"2020","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.drudis.2025.104375_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154490","article-title":"NLRP3 inflammasome pathway in atherosclerosis: focusing on the therapeutic potential of non-coding RNAs","volume":"246","author":"Al-Hawary","year":"2023","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.drudis.2025.104375_b0855","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2015.09.002","article-title":"miRNA nomenclature: a view incorporating genetic origins, biosynthetic pathways, and sequence variants","volume":"31","author":"Desvignes","year":"2015","journal-title":"Trends Genet"},{"key":"10.1016\/j.drudis.2025.104375_b0860","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.drudis.2025.104375_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102377","article-title":"MicroRNAs and synapse turnover in Alzheimer\u2019s disease","volume":"99","author":"Dalal","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.drudis.2025.104375_b0870","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/biomedicines12061322","article-title":"A review of microRNAs and lncRNAs in atherosclerosis as well as some major inflammatory conditions affecting atherosclerosis","volume":"12","author":"Letonja","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104375_b0875","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1441733","article-title":"MiRNA-based therapeutic potential in multiple sclerosis","volume":"15","author":"Zabalza","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104375_b0880","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00210-021-02163-6","article-title":"miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19","volume":"394","author":"Houshmandfar","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.drudis.2025.104375_b0885","first-page":"1167","article-title":"miRNA-20b inhibits cerebral ischemia-induced inflammation through targeting NLRP3","volume":"43","author":"Zhao","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.drudis.2025.104375_b0890","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/cells12172184","article-title":"miR-369-3p modulates intestinal inflammatory response via BRCC3\/NLRP3 inflammasome axis","volume":"12","author":"Scalavino","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104375_b0895","doi-asserted-by":"crossref","first-page":"20254","DOI":"10.3390\/molecules201119688","article-title":"Molecular cloning, expression pattern and genotypic effects on glucoraphanin biosynthetic related genes in Chinese kale (Brassica oleracea var. alboglabra Bailey)","volume":"20","author":"Yin","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104375_b0900","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3389\/fpls.2017.01083","article-title":"Molecular characterization of MYB28 involved in aliphatic glucosinolate biosynthesis in Chinese kale (Brassica oleracea var. alboglabra Bailey)","volume":"8","author":"Yin","year":"2017","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.drudis.2025.104375_b0905","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2021.03.004","article-title":"Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration","volume":"233","author":"Tufekci","year":"2021","journal-title":"Immunol Lett"},{"key":"10.1016\/j.drudis.2025.104375_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120863","article-title":"MicroRNA-122a aggravates intestinal ischemia\/reperfusion injury by promoting pyroptosis via targeting EGFR-NLRP3 signaling pathway","volume":"307","author":"Wang","year":"2022","journal-title":"Life Sci"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:37:35Z","timestamp":1762371455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":182,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1359644625000881"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104375","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome: From drug target to drug discovery","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104375"}}